179 related articles for article (PubMed ID: 19557943)
1. Drug resistance in leprosy: reports from selected endemic countries.
Wkly Epidemiol Rec; 2009 Jun; 84(26):264-7. PubMed ID: 19557943
[No Abstract] [Full Text] [Related]
2. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
[No Abstract] [Full Text] [Related]
3. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of drug resistance in leprosy: 2010.
Wkly Epidemiol Rec; 2011 Jun; 86(23):237. PubMed ID: 21661275
[No Abstract] [Full Text] [Related]
5. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of drug resistance in leprosy: 2009.
Wkly Epidemiol Rec; 2010 Jul; 85(29):281. PubMed ID: 20635520
[No Abstract] [Full Text] [Related]
7. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
Mori S; Yotsu RR; Suzuki K; Makino M; Ishii N
J Dermatol Sci; 2012 Sep; 67(3):192-4. PubMed ID: 22739027
[No Abstract] [Full Text] [Related]
8. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant leprosy: monitoring and current status.
Williams DL; Gillis TP
Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
[No Abstract] [Full Text] [Related]
10. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
11. Evidence for
Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
[No Abstract] [Full Text] [Related]
14. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
15. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
16. An appraisal of medical research in the treatment and control of leprosy.
Rees RJ
Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969
[No Abstract] [Full Text] [Related]
17. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multidrug therapy treatment results between multibacillary leprosy patients in hyperendemic and hypoendemic areas in Gowa Regency, South Sulawesi, Indonesia.
Nawi R
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):340-5. PubMed ID: 15691133
[TBL] [Abstract][Full Text] [Related]
19. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
Almeida JG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
[No Abstract] [Full Text] [Related]
20. Author's reply.
Sengupta U
Indian J Dermatol Venereol Leprol; 2018; 84(4):445. PubMed ID: 29893300
[No Abstract] [Full Text] [Related]
[Next] [New Search]